Executive Chairman & CEO
Lâle White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S. She worked with HCFA and the US Office of the Inspector General to develop the first OIG Model Compliance Program. Lâle was previously Vice President - Finance of Laboratory Corporation of America (NYSE: LH), one of the largest clinical reference laboratories in the US, and its predecessor National Health Laboratories (NYSE: NHLI), where she led the software development of several accounts receivable, inventory, cost accounting and financial management systems for the laboratory industry. Lâle has a BA in finance and an MBA from Florida International University. She is member of the Board of Directors of bioTheranostics, part of the worldwide bioMerieux group, as well as a member of the Board of Directors for CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders. Lâle is a finalist in the San Diego Business Journal 2017 Most Admired CEO Awards.